Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Australian Clinical Labs logo

About Australian Clinical Labs Stock (ASX:ACL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$728.27 million
P/E Ratio
30.38
Dividend Yield
3.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

ACL Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Leadership Transition at Australian Clinical Labs
See More Headlines

ACL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), Coles Group (COL) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:ACL
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.12
Trailing P/E Ratio
30.38
Forward P/E Ratio
N/A
P/E Growth
-0.36
Net Income
A$23.93 million
Net Margins
3.45%
Pretax Margin
N/A
Return on Equity
13.98%
Return on Assets
6.67%

Debt

Debt-to-Equity Ratio
174.00
Current Ratio
0.64
Quick Ratio
0.53

Sales & Book Value

Annual Sales
A$696.37 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
201,830,000
Free Float
N/A
Market Cap
A$728.27 million
Optionable
Not Optionable
Beta
1.18
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (ASX:ACL) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners